Scleroderma, Systemic Completed Phase 1 / 2 Trials for Fludarabine (DB01073)

Also known as: Systemic Scleroderma

IndicationStatusPhase
DBCOND0028174 (Scleroderma, Systemic)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00622895Allogeneic Hematopoietic Cell Transplantation for Severe Systemic SclerosisTreatment